AIC
FBRX icon

AWM Investment Company’s Forte Biosciences FBRX Stock Holding History

AWM Investment Company’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.18M Sell
200,000
-36,821
-16% -$1.06M 0.57% 45
2025
Q4 		$6.46M Sell
236,821
-25,000
-10% -$438K 0.62% 48
2025
Q3 		$3.93M Buy
+261,821
New +$3.02M 0.37% 67

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

AWM Investment Company's FBRX Position: Q1 2026 in Review

AWM Investment Company reduced its Forte Biosciences (FBRX) stake by 16% in Q1 2026, selling an estimated $1.06M and leaving 200,000 shares worth $5.18M. The position accounts for 0.57% of the portfolio, ranked #45.

AWM Investment Company first reported a position in FBRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.46M in Q4 2025. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • AWM Investment Company held 200,000 shares of Forte Biosciences worth $5.18M as of Q1 2026.
  • AWM Investment Company sold 36,821 Forte Biosciences shares in Q1 2026, an estimated $1.06M.
  • Forte Biosciences made up 0.57% of AWM Investment Company's portfolio in Q1 2026, its #45 holding.
  • AWM Investment Company first reported a position in Forte Biosciences in Q3 2025 and has held it in 3 quarters since.
  • AWM Investment Company's Forte Biosciences position peaked at $6.46M in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.